The medical specialty bags market size is expected to see strong growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing focus on sustainable medical packaging, rising demand from home healthcare settings, expansion of chronic disease management, growing investments in advanced material technologies, increasing regulatory emphasis on patient safety. Major trends in the forecast period include increasing demand for non-pvc medical bags, rising adoption of single-use sterile packaging solutions, growing focus on enhanced patient safety and infection control, expansion of specialized dialysis and blood storage bags, improved material performance and shelf-life stability.
The growing prevalence of chronic diseases is poised to drive the expansion of the medical specialty bags market in the future. Chronic diseases are characterized by long-lasting medical conditions, often persisting throughout an individual's lifetime. These medical specialty bags are instrumental in the treatment and management of chronic diseases, providing vital support in various aspects of patient care. For instance, data from the World Health Organization in September 2023 indicates that approximately 74% of the 41 million annual deaths worldwide are attributed to non-communicable diseases (NCDs) or chronic diseases. These NCDs include 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2 million deaths from diabetes. Consequently, the increasing prevalence of chronic diseases is a key driver for the growth of the medical specialty bags market.
Major companies operating in the medical specialty bags market are focusing on technological innovation, such as FDA-approved, ready-to-use premixed intravenous (IV) bags, to enhance workflow efficiency, reduce preparation errors, and improve patient safety in critical care settings. Ready-to-use premixed IV bags combine manufacturer-prepared medications with integrated delivery features and extended shelf life, enabling hospitals to streamline operations, eliminate on-site compounding, reduce drug wastage, and minimize the risk of dosing and contamination errors. For instance, in December 2024, Endo, Inc., a US-based pharmaceutical and medical device company, launched the ADRENALIN Ready-to-Use Premixed Bag, the first and only FDA-approved manufacturer-prepared epinephrine IV bag. The product removes the need for pharmacy compounding or bedside mixing, incorporates single-port IV tubing to prevent inadvertent medication additions, and provides a 24-month shelf life at room temperature. This innovation offers hospitals a safer, faster, and more convenient solution for emergency and critical care administration, underscoring how advanced premixed IV bags are shaping growth in the medical specialty bags market.
In March 2023, Vonco LLC, a US-based medical device manufacturer, made a strategic move by acquiring Genesis Plastics Welding. This acquisition enhances Vonco's capabilities, enabling it to cater to clients seeking specialty medical devices, fluid bags, and other single-use medical items, thereby strengthening its position in the market. Genesis Plastics Welding, the acquired company, specializes in the creation and development of unique single-use medical devices, including fluid bags.
Major companies operating in the medical specialty bags market are Pall Corporation, Fresenius Medical Care AG & Co., Baxter International Inc., B. Braun Medical Inc., Terumo Corporation, Becton Dickinson & Company, C. R. Bard Inc., Hollister Incorporated, Coloplast Corp., Convatec Inc., Nolato AB, Custom Pack Inc., Ambu A/S, Macopharma Inc., Technoflex EN, JMS North America Corporation, Narang Medical Limited, AdvaCare Pharma, Westfield Medical Ltd., Sippex, BL Lifesciences, Kawasumi Laboratories America Inc., Armand Manufacturing Inc., Uniflex Healthcare.
North America was the largest region in the medical specialty bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical specialty bags market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical specialty bags market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the medical specialty bags market by increasing costs of imported medical-grade polymers, packaging films, sterilization materials, and manufacturing machinery. Hospitals and medical device manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressures in export-oriented bag production. These tariffs are increasing procurement costs and impacting pricing of disposable medical products. However, they are also driving regional sourcing of materials, domestic manufacturing expansion, and innovation in alternative and recyclable medical bag materials.
The medical specialty bags market research report is one of a series of new reports that provides medical specialty bags market statistics, including medical specialty bags industry global market size, regional shares, competitors with a medical specialty bags market share, detailed medical specialty bags market segments, market trends and opportunities, and any further data you may need to thrive in the medical specialty bags industry. This medical specialty bags market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medical specialty bags encompass a diverse category of specialized pouches and containers utilized within the medical field, serving a multitude of critical functions. These bags find extensive applications in hospital settings, ensuring the sterile storage of blood and the provision of essential nourishment to patients during surgical procedures and other pivotal medical situations.
The medical specialty bags encompass a range of essential products, including intravenous fluid bags, ostomy bags, sterile packaging bags, continuous ambulatory peritoneal dialysis bags (CAPD), anesthesia and resuscitation bags, as well as other variants. Intravenous fluid bags, commonly referred to as IV bags, are vital components in healthcare settings. These bags consist of a thin tube connected to an intravenous line, and they are constructed from sterile materials. They serve the critical function of delivering fluids, medications, and essential nutrients directly into a patient's bloodstream, effectively preventing dehydration. Various materials, such as polyvinyl chloride (PVC) compounds, polyolefins, and more, are employed in the production of these bags. Medical specialty bags find application across a spectrum of healthcare settings, including hospitals, ambulatory surgical centers, home healthcare, and other relevant contexts.
The medical specialty bags market consists of sales of blood bags, nutrition bags, bioprocess bags and sterilization bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Medical Specialty Bags Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medical specialty bags market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medical specialty bags? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical specialty bags market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Intravenous Fluid Bags; Ostomy Bags; Sterile Packaging Bags; Continuous Ambulatory Peritoneal Dialysis Bags (CAPD); Anesthesia And Resuscitation Bags; Other Products2) By Material: Polyvinyl Chloride (PVC) Compounds; Polyolefins; Other Materials
3) By End-User: Hospitals; Ambulatory Surgical Centers; Home Healthcare; Other End-Users
Subsegments:
1) By Intravenous Fluid Bags: PVC IV Bags; Non-PVC IV Bags; Combination IV Bags2) By Ostomy Bags: Colostomy Bags; Ileostomy Bags; Urostomy Bags
3) By Sterile Packaging Bags: Pouch Bags; Roll Bags; Custom Sterile Packaging Bags
4) By Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags: Standard CAPD Bags; CAPD Bags With Integrated Filters; Specialty CAPD Bags
5) By Anesthesia And Resuscitation Bags: Manual Resuscitators (Ambu Bags); Anesthesia Breathing Circuits; Disposable Anesthesia Bags
6) By Other Products: Drainage Bags; Blood Bags; Collection Bags
Companies Mentioned: Pall Corporation; Fresenius Medical Care AG & Co.; Baxter International Inc.; B. Braun Medical Inc.; Terumo Corporation; Becton Dickinson & Company; C. R. Bard Inc.; Hollister Incorporated; Coloplast Corp.; Convatec Inc.; Nolato AB; Custom Pack Inc.; Ambu A/S; Macopharma Inc.; Technoflex EN; JMS North America Corporation; Narang Medical Limited; AdvaCare Pharma; Westfield Medical Ltd.; Sippex; BL Lifesciences; Kawasumi Laboratories America Inc.; Armand Manufacturing Inc.; Uniflex Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medical Specialty Bags market report include:- Pall Corporation
- Fresenius Medical Care AG & Co.
- Baxter International Inc.
- B. Braun Medical Inc.
- Terumo Corporation
- Becton Dickinson & Company
- C. R. Bard Inc.
- Hollister Incorporated
- Coloplast Corp.
- Convatec Inc.
- Nolato AB
- Custom Pack Inc.
- Ambu A/S
- Macopharma Inc.
- Technoflex EN
- JMS North America Corporation
- Narang Medical Limited
- AdvaCare Pharma
- Westfield Medical Ltd.
- Sippex
- BL Lifesciences
- Kawasumi Laboratories America Inc.
- Armand Manufacturing Inc.
- Uniflex Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.18 Billion |
| Forecasted Market Value ( USD | $ 11.52 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |


